THE PRIMARY RESULTS OF THE MOSAIC TRIAL: DOES CPAP FOR MINIMALLY SYMPTOMATIC OSA REDUCE DAYTIME SLEEPINESS OR CALCULATED VASCULAR RISK? - Craig, SE; Kohler, M; Nicoll, D; Bretton, D; Nunn, A; Davies, R; Stradling, JR (2010)